DE69621805T2 - Bowman-birk-inhibitorzusammensetzungen zur behandlung von entzündungskrankheiten - Google Patents

Bowman-birk-inhibitorzusammensetzungen zur behandlung von entzündungskrankheiten

Info

Publication number
DE69621805T2
DE69621805T2 DE69621805T DE69621805T DE69621805T2 DE 69621805 T2 DE69621805 T2 DE 69621805T2 DE 69621805 T DE69621805 T DE 69621805T DE 69621805 T DE69621805 T DE 69621805T DE 69621805 T2 DE69621805 T2 DE 69621805T2
Authority
DE
Germany
Prior art keywords
inflammatory diseases
treating inflammatory
birk inhibitor
inhibitor compositions
bowman birk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69621805T
Other languages
English (en)
Other versions
DE69621805D1 (de
Inventor
R Kennedy
C Billings
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Publication of DE69621805D1 publication Critical patent/DE69621805D1/de
Application granted granted Critical
Publication of DE69621805T2 publication Critical patent/DE69621805T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/56—Protease inhibitors from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69621805T 1995-07-25 1996-07-25 Bowman-birk-inhibitorzusammensetzungen zur behandlung von entzündungskrankheiten Expired - Fee Related DE69621805T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/507,044 US5614198A (en) 1995-07-25 1995-07-25 Bowman-Birk Inhibitor compositions for treatment of inflammatory disease
PCT/US1996/012173 WO1997004792A1 (en) 1995-07-25 1996-07-25 Bowman-birk inhibitor compositions for treatment of imflammatory disease

Publications (2)

Publication Number Publication Date
DE69621805D1 DE69621805D1 (de) 2002-07-18
DE69621805T2 true DE69621805T2 (de) 2003-03-20

Family

ID=24017040

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69621805T Expired - Fee Related DE69621805T2 (de) 1995-07-25 1996-07-25 Bowman-birk-inhibitorzusammensetzungen zur behandlung von entzündungskrankheiten

Country Status (13)

Country Link
US (1) US5614198A (de)
EP (1) EP0841933B1 (de)
JP (1) JP4026851B2 (de)
KR (1) KR19990035906A (de)
AT (1) ATE218877T1 (de)
AU (1) AU703476B2 (de)
CA (1) CA2223968A1 (de)
DE (1) DE69621805T2 (de)
DK (1) DK0841933T3 (de)
ES (1) ES2176475T3 (de)
NO (1) NO980289D0 (de)
PT (1) PT841933E (de)
WO (1) WO1997004792A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040166183A1 (en) * 1998-05-20 2004-08-26 Ruseler-Van Embden Johanna G. H. Methods and means for preventing or treating inflammation or pruritis
EP0958833A1 (de) * 1998-05-20 1999-11-24 Erasmus Universiteit Rotterdam Verfahren und Mittel zur Vorbeugung oder Behandlung der Entzündung
DE19906108A1 (de) * 1999-02-13 2000-08-17 Univ Eberhard Karls Schutz von Zellen im Zusammenhang mit einer Behandlung mit chemischen Agenzien
US6391848B1 (en) * 1999-04-30 2002-05-21 The Regents Of The University Of California Soybean protein nutraceuticals
US6767564B2 (en) * 2000-09-02 2004-07-27 The Trustees Of The University Of Pennsylvania Use of bowman birk inhibitor for the treatment of multiple sclerosis and other autoimmune diseases
US20080025966A1 (en) * 2004-01-30 2008-01-31 Currie Mark G Methods And Compositions For The Treatment Of Gastrointestinal disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4793996A (en) * 1984-11-14 1988-12-27 Ann R. Kennedy Method of making soybean extract inhibitor
JPS6351335A (ja) * 1986-08-20 1988-03-04 Fuji Oil Co Ltd 肥満細胞脱顆粒抑制剤
US5217717A (en) * 1990-09-06 1993-06-08 Central Soya Company, Inc. Method of making soybean Bowman-Birk inhibitor concentrate and use of same as a human cancer preventative and therapy
US5376373A (en) * 1990-09-06 1994-12-27 Trustees Of The University Of Pennsylvania Method of inhibiting radiation induced weight and hair loss
DE69123960T2 (de) * 1990-10-16 1997-05-07 John Lezdey Behandlung von entzündungen
IT1252865B (it) * 1991-12-31 1995-06-28 Lifegroup Spa N-acilderivati di aminoalcooli attivi come autocoidi locali ed utilizzabili nella terapia dei processi autoimmuni
SE9301911D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptide derivatives

Also Published As

Publication number Publication date
AU703476B2 (en) 1999-03-25
DE69621805D1 (de) 2002-07-18
US5614198A (en) 1997-03-25
JPH11510166A (ja) 1999-09-07
KR19990035906A (ko) 1999-05-25
EP0841933A1 (de) 1998-05-20
NO980289L (no) 1998-01-22
WO1997004792A1 (en) 1997-02-13
EP0841933B1 (de) 2002-06-12
NO980289D0 (no) 1998-01-22
ATE218877T1 (de) 2002-06-15
JP4026851B2 (ja) 2007-12-26
PT841933E (pt) 2002-10-31
EP0841933A4 (de) 1998-08-05
CA2223968A1 (en) 1997-02-13
AU6650196A (en) 1997-02-26
DK0841933T3 (da) 2002-07-15
ES2176475T3 (es) 2002-12-01

Similar Documents

Publication Publication Date Title
DE69837295D1 (de) Probucolbernsteinsäureester zur Hemmung der Expression von VCAM-1
DE69509544D1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
ATE230757T1 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
ATE198044T1 (de) Hydroperoxeicosatetraensäure derivate enthaltende zusammensetzungen und verfahren zur verwendung zur behandlung des trockenen auges
ATE293883T1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
ATE215366T1 (de) 3-benzoylphenylessigsäure-derivate enthaltende topische zusammensetzungen zur behandlung der ophthalmischen entzündungserkrankungen
DE69724016D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege
ATE237633T1 (de) Analogen des keratinozytenwachstumfaktors
DE69728594D1 (de) Chromfreie Zusammensetzung zur Behandlung von Metalloberflächen
ATE257385T1 (de) Zusammensetzungen und verfahren zur behandlung des erhöhten augenindruckes
DE69530860D1 (de) Behandlung der entzündung des sehnervs
DE69519577D1 (de) Prednisolonmetasulfobenzoatzusammensetzung zur behandlung von entzündungserkrankung des darmes
DE69720996D1 (de) Neue pharmazeutische zusammensetzungen von steroid-nitratester zur verwendung als enzündungshemmer
DE69027220D1 (de) Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
DK0988040T3 (da) Anvendelse af glucosamin og glucasamin-derivater til hurtig lindring af klöe eller lokaliseret smerte
DE69621805D1 (de) Bowman-birk-inhibitorzusammensetzungen zur behandlung von entzündungskrankheiten
ATE190843T1 (de) Zubereitungen zur behandlung von impotenz, die ein alpha-1 inhibitor und ein alpha-2 inhibitor enthalten
TR199700435A2 (xx) Pestisit florolefin bile�imlerinin haz�rlanmas� i�in i�lem ve ara bile�imler.
ATE241383T1 (de) Behandlung von allergischen zuständen mit cystein-und serin-proteinase inhibitoren
DE69003532D1 (de) Therapeutische zusammensetzung und kit für die behandlung der rheumatischen polyarthritis.

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8339 Ceased/non-payment of the annual fee